For example, under inflammatory conditions, ATG16L1 deletion in myeloid cells exerts limited effect on IBD, whereas ATG16L1 deletion in ICE will increases IEC apoptosis, aggravates chronic inflammation. Here, ATG16L1 is linked to inflammatory bowel disease.